These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682 [TBL] [Abstract][Full Text] [Related]
14. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Braun S; Schrötter H; Schmeisser A; Strasser RH Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747 [TBL] [Abstract][Full Text] [Related]
16. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M; J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728 [TBL] [Abstract][Full Text] [Related]
20. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report. Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]